Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis

By Devogelaer J.   Brown J.   Burckhardt P.   Meunier P.   Goemaere S.   Lippuner K.   Body J.   Samsioe G.   Felsenberg D.   Fashola T.   Sanna L.   Ortmann C.   Trechsel U.   Krasnow J.   Eriksen E.   Garnero P.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1211-1218

Springer Publishing Company

Access to resources Recommend Favorite

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis

By Taggart H.   Cheng J.   Archbold P.  

Osteoporosis International, Vol. 21, Iss. 9, 2010-09 ,pp. : 1621-1622

Springer Publishing Company

Access to resources Recommend Favorite

Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis

By  

JOURNAL OF ORTHOPAEDIC RESEARCH, Vol. 33, Iss. 9, 2015-09 ,pp. : 1297-1304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial

By Eastell R.   Lang T.   Boonen S.   Cummings S.   Delmas P.   Cauley J.   Horowitz Z.   Kerzberg E.   Bianchi G.   Kendler D.   Leung P.   Man Z.   Mesenbrink P.   Eriksen E.   Black D.  

Osteoporosis International, Vol. 21, Iss. 7, 2010-07 ,pp. : 1277-1285

Springer Publishing Company

Access to resources Recommend Favorite

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial

By Adachi J.   Lyles K.   Colón-Emeric C.   Boonen S.   Pieper C.   Mautalen C.   Hyldstrup L.   Recknor C.   Nordsletten L.   Moore K.   Bucci-Rechtweg C.   Su G.   Eriksen E.   Magaziner J.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2539-2549

Springer Publishing Company

Access to resources Recommend Favorite